Alkermes Investigational Site — Atlanta, Georgia

Alkermes Investigational Site is a clinical research site located in Atlanta, Georgia, United States 30303.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Alkermes Investigational Site has participated in 30 clinical trials with 1 currently active.

Therapeutic areas: Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder.

Sponsors: Alkermes, Inc., Biogen.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alkermes Investigational Site?

Alkermes Investigational Site has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alkermes Investigational Site conducted?

Alkermes Investigational Site has 30 clinical trials on record, with 1 currently active. Their work covers Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder.

Is Alkermes Investigational Site accredited by Crixeo Health?

Yes — Alkermes Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Alkermes Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.